A novel bisphosphonate minodronate (YM529) specifically inhibits osteolytic bone metastasis produced by human small-cell lung cancer cells in NK-cell depleted SCID mice

Author: Zhang Helong   Yano Seiji   Miki Toyokazu   Goto Hisatsugu   Kanematsu Takanori   Muguruma Hiroaki   Uehara Hisanori   Sone Saburo  

Publisher: Springer Publishing Company

ISSN: 0262-0898

Source: Clinical and Experimental Metastasis, Vol.20, Iss.2, 2003-03, pp. : 153-159

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content